A chromatin-focused RNAi screen in mouse AML cells shows that suppression of PRC2 (Polycomb Repressive Complex 2) histone methyltransferase to transcriptionally silence chromatin, promotes JQ1 resistance in AML. This evidence concerns the gene PRDM9 and acute myeloid leukemia.